Neuralink's DJ Seo: Inside the Race to Connect Brains and AI

Why It Matters

Neuralink’s progress could dramatically expand autonomy for disabled individuals while ushering a new era of AI‑enhanced cognition, reshaping healthcare and the broader technology landscape.

Key Takeaways

• Neuralink’s Telepathy restores communication for quadriplegic ALS patients.
• BlindSight aims to give vision via cortical stimulation and external cameras.
• Vertical integration enables rapid scaling of surgical robots and implant production.
• AI integration targets high‑bandwidth brain‑computer interfaces beyond keyboard control.
• Patient caregivers’ support is crucial for successful Neuralink clinical outcomes.

Summary

The video showcases Neuralink co‑founder DJ Seo discussing the company’s flagship brain‑computer interface (BCI) products—Telepathy, which lets locked‑in ALS patients control a computer with thought, and the upcoming BlindSight system that could restore vision by stimulating the visual cortex with data from an external camera. Seo emphasizes that the original motivation was to bridge the I/O bottleneck between human intent and artificial intelligence, and that scaling the technology from the outset—through vertical integration of chip design, surgical robots, and manufacturing—has been a core strategic advantage. Key insights include the tangible clinical impact of Telepathy on over twenty patients, the technical roadmap for BlindSight that hinges on increasing electrode density to generate high‑resolution phosphenes, and the emerging “neural foundational model” where large‑scale AI transformers are fine‑tuned on neural data to decode intent directly. Seo stresses that scale, both in participant numbers and hardware production, is the catalyst that will shift BCIs from keyboard‑mouse proxies to true high‑bandwidth exocortical extensions. Notable remarks from Seo highlight the underappreciated role of caregivers—family members who enable trial participation—and the relentless “all‑green‑light” schedule inspired by Elon Musk, which strips away administrative bottlenecks to accelerate engineering cycles. He also frames AI as an exocortex, suggesting future BCIs could bypass conventional interfaces and enable direct, multimodal concept transfer. The implications are profound: if Neuralink’s scaling strategy succeeds, BCIs could become a mass‑market medical device, reshaping care for paralysis, blindness, and potentially augmenting cognitive function. The convergence of high‑density neural hardware with large‑scale AI models promises a new layer of human‑machine symbiosis, raising both commercial opportunities and regulatory, ethical, and societal challenges.

Original Description

DJ Seo, co-founder and president of Neuralink, joins Sequoia partner Shaun Maguire at AI Ascent 2026 to talk about what it takes to build the bridge between the human brain and AI. He walks through how Neuralink has gone from one human patient to over twenty, what it has been like to watch quadriplegic patients regain control of computers and robotic limbs through pure thought, and where Blindsight — the company's vision-restoration product — stands today. Also: why DJ believes AI will eventually become an exocortex layered above the human neocortex, why the real ceiling of this technology is "direct, uncompressed, multimodal transfer of concepts" between minds and machines, and what he has learned working alongside Elon Musk on a problem the world of atoms refuses to make easy.

00:00 Introduction

00:21 Telepathy Patient Stories

01:06 Convoy Robotics Independence

02:04 Blindsight Vision Restore

03:10 After Video Reflections

03:31 Origin Story And AI

06:31 Scaling And Vertical Integration

09:27 Caregivers And Purpose

13:10 BCIs Meet AI Future

21:05 Audience Q&A Wrap